Acute kidney injury in COVID-19: a case-report

Mauro, Marco Di; Migliaccio, Marco Giuseppe; Ricciolino, Riccardo; Spiniello, Giorgio; Carfora, Vincenzo; Verde, Nicoletta; Mottola, Filiberto Fausto; Coppola, Nicola

doi:10.1007/s11255-020-02635-3

Cited by 1 publication

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Renal involvement has been recognized as a significant characteristic of COVID-19, including acute renal failure (AKI), and is noted in 20-50% of hospitalized patients. (6)(7)(8)(9)(10)(11) The first patient developed AKI in the three days of admission, while the second and third patients had AKI from the first day of admission. Data from China suggest the incidence of AKI among hospitalized patients with COVID-19 ranges from 5 to 23%, with AKI usually manifesting during the second week of infection.…”

Section: Discussion Smentioning

confidence: 99%

See 1 more Smart Citation

Treatment Challenge in COVID-19 Patients with Acute Kidney Injury in Hospital

Pratama

Rifai

Sianturi

2022

CRJIM

View full text Add to dashboard Cite

Renal, the main characteristic of COVID-19 infection. Acute kidney injury (AKI) has been documented in 20-50% of the hospitalized COVID-19 patients. Renal involvement among COVID-19 patients might be multifactorial. COVID-19 Patients with AKI significantly had higher mortality than patients without AKI. This case series reported severe COVID-19 with respiratory failure and AKI during admission to the hospital. All patients were admitted to the intensive care unit (ICU) and obtained the standard therapeutic protocols according to the COVID-19 severities. The first patient developed AKI in the three days of admission, while the second and third patients had AKI from the first day of admission. The patients had similar complications, including type 1 or 2 respiratory failures, secondary infection with sepsis, hyperpotassemia, and metabolic acidosis. The first and second patients underwent hemodialysis as indicated on these patients. However, the evaluation of their renal functions did not improve after that. The third patient did not receive the hemodialysis therapy and only obtained supportive treatment with adequate fluid therapy. The third patient was getting better on the 16th day of admission. In addition, the renal function test was getting normal after the 16th day of admission. The patient was discharged on the 19th day of admission in stable condition. Early recognition of renal involvement in COVID-19 infection, preventive measures, renal function monitoring, and therapeutic intervention were essential to reduce the morbidity and mortality of COVID-19 patients. Hospitalized patients should be monitored closely for their renal function to prevent renal function deterioration in the future.

show abstract

Section: Discussion Smentioning

confidence: 99%

“…(6) According to Europe and the United States data, AKI is considered a marker of disease severity and an adverse prognostic factor for survival. (7)(8)(9) Handling COVID-19 patients who experience AKI is still a challenge in medical expertise. As many as 20% of patients admitted to the intensive care unit with COVID-19 require renal replacement therapy.…”

mentioning

confidence: 99%